Dissecting the Potential Interplay of DEK Functions in Inflammation and Cancer

por Pease, Nicholas A., Wise-Draper, Trisha, Privette Vinnedge, Lisa
Publicado 2015

Novel molecular mechanisms in Alzheimer’s disease: The potential role of DEK in disease pathogenesis

por Greene, Allie N., Solomon, Matia B., Privette Vinnedge, Lisa M.
Publicado 2022

Loss of DEK Expression Induces Alzheimer’s Disease Phenotypes in Differentiated SH-SY5Y Cells

por Greene, Allie N., Parks, Lois G., Solomon, Matia B., Privette Vinnedge, Lisa M.
Publicado 2020

The DEK Oncogene Is a Target of Steroid Hormone Receptor Signaling in Breast Cancer

por Privette Vinnedge, Lisa M., Ho, Shuk-Mei, Wikenheiser-Brokamp, Kathryn A., Wells, Susanne I.
Publicado 2012

Drug resistance mechanisms create targetable proteostatic vulnerabilities in Her2+ breast cancers

por Singh, Navneet, Romick-Rosendale, Lindsey, Watanabe-Chailland, Miki, Privette Vinnedge, Lisa M., Komurov, Kakajan
Publicado 2022

The human DEK oncogene stimulates beta catenin signaling, invasion and mammosphere formation in breast cancer

por Privette Vinnedge, Lisa M., McClaine, Rebecca, Wagh, Purnima K., Wikenheiser-Brokamp, Kathryn A., Waltz, Susan E., Wells, Susanne I.
Publicado 2011

The DEK oncogene promotes cellular proliferation through paracrine Wnt signaling in Ron receptor positive breast cancers

por Privette Vinnedge, Lisa M., Benight, Nancy M., Wagh, Purnima K., Pease, Nicholas A., Nashu, Madison A., Serrano-Lopez, Juana, Adams, Allie K., Cancelas, Jose A., Waltz, Susan E., Wells, Susanne I.
Publicado 2014

Decreased plasma DEK Oncogene Levels Correlate with p16-Negative Disease and Advanced Tumor Stage in a Case–Control Study of Patients with Head and Neck Squamous Cell Carcinoma

por Wise-Draper, Trisha, Sendilnathan, Arun, Palackdharry, Sarah, Pease, Nicholas, Qualtieri, Julianne, Butler, Randall, Sadraei, Nooshin Hashemi, Morris, John C., Patil, Yash, Wilson, Keith, Mark, Jonathan, Casper, Keith, Takiar, Vinita, Lane, Adam, Privette Vinnedge, Lisa
Publicado 2017

Defective transcription elongation in a subset of cancers confers immunotherapy resistance

por Modur, Vishnu, Singh, Navneet, Mohanty, Vakul, Chung, Eunah, Muhammad, Belal, Choi, Kwangmin, Chen, Xiaoting, Chetal, Kashish, Ratner, Nancy, Salomonis, Nathan, Weirauch, Matthew T., Waltz, Susan, Huang, Gang, Privette-Vinnedge, Lisa, Park, Joo-Seop, Janssen, Edith M., Komurov, Kakajan
Publicado 2018